Tower Research Capital LLC (TRC) - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2020$123,000
-79.8%
49,918
-74.2%
0.00%
-42.9%
Q3 2020$610,000
+246.6%
193,754
+220.1%
0.01%0.0%
Q2 2020$176,000
+1855.6%
60,525
+1709.4%
0.01%
+600.0%
Q1 2020$9,000
+12.5%
3,345
+24.8%
0.00%0.0%
Q4 2019$8,000
-57.9%
2,681
-69.6%
0.00%0.0%
Q3 2019$19,000
+1800.0%
8,828
+2842.7%
0.00%
Q2 2019$1,0000.0%300
-9.6%
0.00%
Q1 2019$1,000
-92.3%
332
-93.2%
0.00%
-100.0%
Q3 2018$13,000
-35.0%
4,890
-42.9%
0.00%0.0%
Q2 2018$20,000
-4.8%
8,570
+17.8%
0.00%
-50.0%
Q1 2018$21,000
+61.5%
7,275
+53.9%
0.00%0.0%
Q4 2017$13,000
-31.6%
4,727
-16.9%
0.00%0.0%
Q3 2017$19,000
+171.4%
5,687
+89.4%
0.00%
+100.0%
Q2 2017$7,000
+133.3%
3,003
+213.5%
0.00%
Q2 2016$3,000
-78.6%
958
-77.7%
0.00%
-100.0%
Q1 2016$14,000
-6.7%
4,300
-0.2%
0.00%0.0%
Q4 2015$15,000
+1400.0%
4,307
+4250.5%
0.00%
Q1 2015$1,000
-95.7%
99
-96.8%
0.00%
-100.0%
Q4 2014$23,0003,063
+61160.0%
0.00%
Q3 2014$0
-100.0%
5
-95.0%
0.00%
Q2 2014$1,000
-98.0%
100
-98.4%
0.00%
-100.0%
Q1 2014$51,000
+2450.0%
6,086
+2973.7%
0.01%
Q4 2013$2,000
-98.1%
198
-98.5%
0.00%
-100.0%
Q3 2013$107,00013,4500.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2018
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders